Rani Therapeutics Holdings, Inc.
RANI
$1.10
$0.00010.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.03M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03M | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.03M | -- | -- | -- | -- |
| SG&A Expenses | 23.95M | 24.31M | 25.32M | 26.12M | 26.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.63M | 51.79M | 57.85M | 63.62M | 66.10M |
| Operating Income | -49.60M | -51.79M | -57.85M | -63.62M | -66.10M |
| Income Before Tax | -56.58M | -54.92M | -60.53M | -65.83M | -67.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.58 | -54.92 | -60.53 | -65.83 | -67.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 26.57M | 26.75M | 29.94M | 32.75M | 33.91M |
| Net Income | -30.02M | -28.17M | -30.58M | -33.08M | -33.97M |
| EBIT | -49.60M | -51.79M | -57.85M | -63.62M | -66.10M |
| EBITDA | -48.57M | -50.80M | -56.90M | -62.74M | -65.28M |
| EPS Basic | -1.06 | -1.06 | -1.18 | -1.29 | -1.33 |
| Normalized Basic EPS | -0.24 | -0.28 | -0.30 | -0.33 | -0.33 |
| EPS Diluted | -1.06 | -1.06 | -1.18 | -1.29 | -1.33 |
| Normalized Diluted EPS | -0.24 | -0.28 | -0.30 | -0.33 | -0.33 |
| Average Basic Shares Outstanding | 113.85M | 107.07M | 103.78M | 102.81M | 102.01M |
| Average Diluted Shares Outstanding | 113.85M | 107.07M | 103.78M | 102.81M | 102.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |